Successful Treatment of Tourette Syndrome With a Combination of Guanfacine and Aripiprazole: A Case Series.

aripiprazole guanfacine motor tic tourette's syndrome vocal tic

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
May 2023
Historique:
accepted: 27 05 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Tourette syndrome (TS) is a disorder of the nervous system that causes motor and vocal tics. Tics occur as sudden onset, rapid stereotyped purposeless movements or sounds. Combination therapies can be utilized for adequate control of motor and vocal tics. Patients diagnosed with TS and treated with aripiprazole and guanfacine from 2011-2022 at Saint Louis University Hospital were retrospectively surveyed. Three patients with TS treated with aripiprazole and guanfacine experienced significant improvement or complete resolution of their motor and vocal tics. In our cohort of three patients, the combination of guanfacine and aripiprazole significantly improved or resolved motor and vocal tics that were previously poorly controlled on other traditional medications.

Identifiants

pubmed: 37378108
doi: 10.7759/cureus.39573
pmc: PMC10292806
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e39573

Informations de copyright

Copyright © 2023, George et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Front Neurosci. 2016 Sep 12;10:416
pubmed: 27672358
BMC Psychiatry. 2015 Mar 11;15:46
pubmed: 25879205
Neurology. 2003 Apr 8;60(7):1130-5
pubmed: 12682319
Dan Med J. 2018 Apr;65(4):
pubmed: 29619935
Eur Child Adolesc Psychiatry. 2011 Apr;20(4):153-4
pubmed: 21445722
Expert Rev Neurother. 2021 Apr;21(4):381-391
pubmed: 33612035
Pharmacopsychiatry. 2019 Jan;52(1):7-15
pubmed: 29506305
Expert Opin Drug Saf. 2020 Nov;19(11):1419-1444
pubmed: 32892632
ACS Chem Neurosci. 2018 Apr 18;9(4):651-672
pubmed: 29498507
Curr Neuropharmacol. 2019;17(8):703-709
pubmed: 30152283
Neurosci Biobehav Rev. 2013 Jul;37(6):1069-84
pubmed: 23085211
Pediatric Health Med Ther. 2016 Jun 27;7:57-64
pubmed: 29388585
Eur Child Adolesc Psychiatry. 2022 Mar;31(3):425-441
pubmed: 34757514
J Psychiatr Res. 2013 Aug;47(8):1007-12
pubmed: 23664673
J Psychopharmacol. 2021 Sep;35(9):1037-1061
pubmed: 34286606
Neurology. 2019 May 7;92(19):907-915
pubmed: 31061209
Curr Dev Disord Rep. 2019 Sep;6(3):159-172
pubmed: 32467820
World Psychiatry. 2020 Jun;19(2):214-232
pubmed: 32394557
Fac Rev. 2021 Sep 07;10:70
pubmed: 34557874

Auteurs

Tikku George (T)

Neurology, Saint Louis University School of Medicine, Saint Louis, USA.

Mallory Emig (M)

Neurology, Saint Louis University School of Medicine, Saint Louis, USA.

Pratap Chand (P)

Neurology, Saint Louis University School of Medicine, Saint Louis, USA.

Heer Hendry (H)

Neurology, Saint Louis University School of Medicine, Saint Louis, USA.

Classifications MeSH